The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters.
about
Infection with MERS-CoV causes lethal pneumonia in the common marmosetAnimal models for SARS and MERS coronavirusesReceptor-binding domain-based subunit vaccines against MERS-CoVCurrent advancements and potential strategies in the development of MERS-CoV vaccinesAnimal models of Middle East respiratory syndrome coronavirus infectionSearching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirusRapid generation of a mouse model for Middle East respiratory syndrome.The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic.Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.Bat origin of human coronaviruses.The emergence of the Middle East respiratory syndrome coronavirusHost species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronavirusesSearching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseCD26/DPP4 cell-surface expression in bat cells correlates with bat cell susceptibility to Middle East respiratory syndrome coronavirus (MERS-CoV) infection and evolution of persistent infection.Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infectionsA truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccinesGeneration of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease.Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits.Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus.Evaluation of candidate vaccine approaches for MERS-CoV.Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus.Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge.Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesisCharacterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and DiseaseMiddle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4.Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)Development of animal models against emerging coronaviruses: From SARS to MERS coronavirusA review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis.Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus.Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitorsMiddle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations.Coronaviruses: important emerging human pathogens.Pathogenesis of Middle East respiratory syndrome coronavirus.Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.A Comparative Review of Animal Models of Middle East Respiratory Syndrome Coronavirus Infection.Vaccines for the prevention against the threat of MERS-CoV.Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods.
P2860
Q21131359-11974F7E-1A43-411F-88C9-837781C0A4F8Q26799857-EB74222D-C5F5-4B04-BBDE-40E1F9A38308Q26851979-FA906A35-7B66-46FE-A8BD-8EAA0025BF13Q27012578-B5A7B23E-D21F-4722-B283-B7D17E2550CEQ28086778-497E3595-1A45-4BBB-9BD7-948F09D64DE4Q28873816-5C2DAB1B-1E01-4B0A-93A6-D91A0558C528Q30217177-828E2E3B-511A-4E7E-8245-70DFB9A335AFQ30235533-C84DCAA5-244A-4C63-9A16-71A62824F9A8Q30368736-0A88F50E-C30F-4106-8BA9-D1F844F5CDF3Q30382750-D61EE1AA-AAC0-4300-B45A-8AFAEA806474Q33934034-5B815870-6B90-435A-BDFC-F539315BD681Q34059153-CFEC36B5-3BEC-4CDA-8EC9-087617ED06B0Q34261516-C0FCC2B1-0172-4C8E-947A-45B12483ADA7Q34324907-56E20AA2-3FFD-4653-9B51-2E35491E90BEQ34468689-A849A516-A5D2-45E4-9986-58BAF0780D94Q34542015-01DC372D-D649-4983-B6F2-89EAF2072CB2Q35019893-0C286048-03BA-4640-96D1-14A881C9C791Q35063993-DD2BF9D0-DDB1-408A-A89C-2E2880F8CD80Q35487986-9AC8B9E7-BA3F-41EC-9CC0-E08E6D6A2C1EQ35641228-1A990A17-8CB5-4FC1-8244-4D4E4B73F9A8Q35877765-7C3FEF02-312B-4A73-9517-F63CCC15F187Q35917397-6E64E37F-E93E-461C-B53F-93972B20F3CEQ36012570-F57AC5A5-5878-4EA0-912F-812B632FAB77Q36252666-4BE32490-6741-4EF4-9F72-7346BDB71465Q36393296-0FFB8E36-A916-4D8E-BB7B-9FF6175B27B1Q36433987-B2E03D72-FD03-440F-9359-81B07EC807A0Q36562859-02918B98-1907-4EDB-BAA7-7EF514FCF1A6Q36602236-8E8D939E-2B0B-4BE5-BCAC-4719E4F60EABQ36691163-860325BC-CAE3-402F-B639-0A294036DAF1Q36739375-9FF47E48-73F1-4737-A71A-BB816A7934EBQ37169882-2B54457D-EC7D-4896-8D48-E78FB60B437CQ37565476-2BD01648-5A81-4104-8385-639E809B752FQ37596746-5DC7BE11-DB74-4D8F-B130-E2B227FFCCB5Q38187028-0FF6F4A8-7FB0-4240-82B8-28A5D6D1A67DQ38193770-A34BDB2B-F802-4028-8764-77440ED1060CQ38258027-0DFC564B-A361-4F3F-BC2C-8DAAA34A2274Q38619800-95935482-E8E2-429D-9C36-DAE8225B3297Q38730484-24F7B726-2BF3-4758-8954-099AB582D918Q38778044-84529C1B-2F61-4F2C-A893-8877E2B83ECFQ38813119-A3A629C3-CA92-425C-9705-81DBD29CA32B
P2860
The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The Middle East respiratory sy ...... replicate in Syrian hamsters.
@en
type
label
The Middle East respiratory sy ...... replicate in Syrian hamsters.
@en
prefLabel
The Middle East respiratory sy ...... replicate in Syrian hamsters.
@en
P2093
P2860
P50
P1433
P1476
The Middle East respiratory sy ...... replicate in Syrian hamsters.
@en
P2093
Elaine Haddock
Joseph Prescott
Laura Baseler
Matthew G Lackemeyer
Shauna Milne-Price
Tina Thomas
P2860
P304
P356
10.1371/JOURNAL.PONE.0069127
P407
P577
2013-07-02T00:00:00Z